pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,594 catalysts · 7,208 phase readout · 2,441 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: phase readout×type: earnings×clear all
type
  • phase readout7,208
  • 8k filing2,441
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

44
›RECRUITINGphase readoutNCT07519109: Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Postoperative Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT05374109: SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth

Sponsor: Duke University. Phase: NA. Conditions: HIV-1-infection, Mental Health Issue, Adherence, Medication

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07755709: Ultrasound Scoring System for Diagnosis and Prediction of Severity and Surgical Outcomes of Placenta Accreta Spectrum

Sponsor: Sohag University. Phase: . Conditions: Placenta Accreta, Third Trimester

full page →ctgov ↗
›RECRUITINGphase readoutNCT07073209: PENG vs Femoral Block for Hip Fracture Analgesia

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Hip Fractures

full page →ctgov ↗
›COMPLETEDphase readoutNCT01579409: Impact of Dietary Status on Vascular Function Before and After a Standardized Breakfast. An "Exposed/Unexposed" Study Embedded in the SUVIMAX2 Cohort

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE4. Conditions: French PNNS Guidelines in Vascular Function

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06536309: Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Sponsor: Brigham and Women's Hospital. Phase: PHASE4. Conditions: Heart Failure With Preserved Ejection Fraction, Myocardial Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06002607: Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections

Sponsor: University of California, Irvine. Phase: . Conditions: Necrotizing Soft Tissue Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07420907: Study of the Progression of Chronic Cardiovascular Conditions

Sponsor: Prolaio. Phase: . Conditions: Cardiovascular Disease (CVD), Heart Failure, Aortic Stenosis, Aortic Stenosis Disease, Hypertension, Hypertension (HTN), Hypertrophic Cardiomyopathy Patients, Hypertrophic Cardiomyopathy Without Obstruction, Hypertrophic Cardiomyopathy, Obstructive, Dilated Cardiomyopathy (DCM), Dilated Cardiomyopathy, Dilated Cardiomyopathy, Familial

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07679607: GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

Sponsor: University of Maryland, Baltimore. Phase: PHASE2. Conditions: Lung Cancer (NSCLC), Radiation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07789392: Patient-specific PEEK Implants for Post-maxillectomy Orbital Floor Reconstruction

Sponsor: Alexandria University. Phase: PHASE4. Conditions: Orbital Floor Reconstruction, PEEK IMPLANTS, MAXILLECTOMY

full page →ctgov ↗
›RECRUITINGphase readoutNCT07370792: Contribution of Optical Genome Mapping (OGM) in the Diagnosis of Multiple Congenital Malformations With or Without Intellectual Disability Without Genetic Abnormality

Sponsor: Céline PEBREL-RICHARD. Phase: NA. Conditions: Congenital Malformations

full page →ctgov ↗
›RECRUITINGphase readoutNCT04829136: Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Hematopoietic and Lymphatic System Neoplasm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06131411: Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies

Sponsor: Azienda Ospedaliero-Universitaria Careggi. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07536971: Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions

Sponsor: Beijing Obstetrics and Gynecology Hospital. Phase: NA. Conditions: Intrauterine Adhesions

full page →ctgov ↗
›COMPLETEDphase readoutNCT01838434: Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE1. Conditions: Relapsed/Refractory Mantle Cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04532944: The Energetic Origin of Neurodegeneration in MS

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06905834: Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE2. Conditions: Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07394634: Efficiency of Self Extracted Tooth Graft in Extraction Socket : A Clinical and Radiographic Study

Sponsor: Mahsa University. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06413134: KPAP Adherence Crossover Study

Sponsor: SleepRes Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea

full page →ctgov ↗
›COMPLETEDphase readoutNCT06064734: Low-Frequency REpetitive TRanscranial Magnetic Stimulation in ACute Ischemic StrokE Within 48 Hours

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Stroke, Acute, Stroke, Ischemic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07475299: Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy. Phase: NA. Conditions: Irritable Bowel Syndrome (IBS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07788599: Strengthening, Guidance, Health, Empowerment

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: HIV Infection, Syphilis, Gonorrhea Infection, Chlamydia Infection, Hepatitis B, Hepatitis C

full page →ctgov ↗
›RECRUITINGphase readoutNCT06953999: A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

Sponsor: Akeso. Phase: PHASE3. Conditions: Pancreatic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03926299: Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

Sponsor: Prof. Dr. Volker Viereck. Phase: NA. Conditions: Chronic Skin Disease, Vulvar Lichen Sclerosus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07514663: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile

Sponsor: Midwest Center for Metabolic and Cardiovascular Research. Phase: NA. Conditions: Hypercholesterolemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07463963: Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Bladder Cancer, Transurethral Resection of the Bladder, Urinary Tract Infection Bacterial

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07687563: Intrinsic Capacity, Resilience, and Meaning in Life in Community-Dwelling Midlife and Older Adults

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Healthy Ageing, Community-dwelling Older Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT06561893: Effect of L. Plantarum Probiotic Supplementation on Broccoli Sulforaphane Bioavailability: Randomised Double-blind Placebo-controlled Crossover Study

Sponsor: University of Exeter. Phase: NA. Conditions: Nutrition, Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07421193: Effect of Video-Based Games on Upper Extremity Function in Children With Hemiparetic Cerebral Palsy

Sponsor: Pamukkale University. Phase: NA. Conditions: Cerebral Palsy, Video Game

full page →ctgov ↗
›RECRUITINGphase readoutNCT07528014: ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1

Sponsor: Salma Health, Inc.. Phase: . Conditions: Depressed Mood

full page →ctgov ↗
›RECRUITINGphase readoutNCT05286814: PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Intrahepatic Bile Duct Cancer, Colorectal Neoplasms, Colorectal Cancer, Cholangiocarcinoma, Bile Duct Neoplasms, Bile Duct Cancer, Adrenocortical Carcinoma (ACC), Adrenal Cortical Carcinoma, Adrenal Gland Cancer, Adrenal Gland Neoplasms, Adrenal Cortex Neoplasms

full page →ctgov ↗
›COMPLETEDphase readoutNCT04895306: Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)

Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Pain, Opioid Use, Androgen Deficiency, Back Pain

full page →ctgov ↗
›TERMINATEDphase readoutNCT05181904: Gastric Content Ultrasound Monitoring Prior to Extubation in Critically Ill Children

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Fasting, Pediatric ALL, Aspiration

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06999304: Pilot TMS in Mild TBI

Sponsor: HealthPartners Institute. Phase: NA. Conditions: Persistent Post Concussive Headache, Mild Traumatic Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06267404: Effectiveness of Iliopsoas Positional Release Versus Conventional Exercises in the Management of Sub-acute Back Pain.

Sponsor: University of Karachi. Phase: NA. Conditions: Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07390604: Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: . Conditions: Lipoprotein(a), Lipoprotein-apheresis, Double-filtration Plasmapheresis, Hemodialysis Complication, End Stage Chronic Renal Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT05237804: Evaluation of an Intervention to Reduce the Time to Treatment for TAVI Patients

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Aortic Valve Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07676084: Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Sponsor: Andover Research Eye Institute. Phase: PHASE4. Conditions: Dry Eye Disease (DED)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07484984: Scapular Depression at Rest: Implications for Cervical Pain and Functional Outcomes

Sponsor: Cairo University. Phase: . Conditions: Neck Pain, Neck Disability

full page →ctgov ↗
›COMPLETEDphase readoutNCT05726552: The Effect of Laughter Therapy on Hemodialysis Patients

Sponsor: Zonguldak Bulent Ecevit University. Phase: NA. Conditions: Laughter Therapy, Depression, Anxiety, Hemodialysis, Life Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT07109349: tAN for First Responders

Sponsor: Spark Biomedical, Inc.. Phase: NA. Conditions: Mental Fatigue, Mental Stress

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07472452: MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI

Sponsor: Ankara Etlik City Hospital. Phase: . Conditions: Acute Kidney Injury, Sepsis, Critical Illness, Renal Resistive Index

full page →ctgov ↗
›COMPLETEDphase readoutNCT07389252: Fascial Manipulation on Scapulohumeral Rhythm and Proprioception in Patients With Rotator Cuff Tendinitis.

Sponsor: Riphah International University. Phase: NA. Conditions: Rotator Cuff Tendinitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06068049: OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

Sponsor: AstraZeneca. Phase: . Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
← prev
page 152 of 152
next →